Follow-up of intensive glucose control in type 2 diabetes. de réir Lund, S, Rossing, P, Vaag, A

The Danish Adult Diabetes Registry de réir Jørgensen ME, Kristensen JK, Reventlov Husted G, Cerqueira CS, Rossing P

Faigh an téacs iomlán

The drivers of non-adherence to albuminuria testing guidelines and the clinical and economic impact of not identifying chronic kidney disease de réir Groehl, F, Garreta-Rufas, A, Meredith, K, Harris, J, Rossing, P, Hobbs, FDR, Wanner, C

Characterization of renal biomarkers for use in clinical trials: effect of preanalytical processing and qualification using samples from subjects with diabetes de réir Brott DA, Furlong ST, Adler SH, Hainer JW, Arani RB, Pinches M, Rossing P, Chaturvedi N

Faigh an téacs iomlán

New Diabetic Treatment by Alleviation of Autonomic Nervous System Dysfunction Measured as Periosteal Pressure Sensitivity at Sternum Improves Empowerment, Treatment Satisfaction, a... de réir Hecquet SK, Ballegaard S, Eldrup E, Hansen CS, Hansen TW, Harboe GS, Rossing P, Pichat CSH, Watt T, Gyntelberg F, Ørsted N, Faber JO

Faigh an téacs iomlán

Estimated health economic impact of conducting urine albumin-to-creatinine ratio testing alongside estimated glomerular filtration rate testing in the early stages of chronic kidne... de réir Rossing, P, Groehl, F, Mernagh, P, Folkerts, K, Garreta-Rufas, A, Harris, J, Meredith, K, Carter, M, Åkerborg, Ö, Wanner, C, Hobbs, FDR

Challenges in conducting clinical trials in nephrology: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference de réir Baigent, C, Herrington, W, Coresh, J, Landray, M, Levin, A, Perkovic, V, Pfeffer, M, Rossing, P, Walsh, M, Wanner, C, Wheeler, D, Winkelmayer, W, McMurray, J

Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis de réir Currie, G, Taylor, A, Fujita, T, Ohtsu, H, Lindhardt, M, Rossing, P, Boesby, L, Edwards, N, Ferro, C, Townend, J, van den Meiracker, A, Saklayen, M, Oveisi, S, Jardine, A, Delles, C, Preiss, D, Mark, P

Effects of Dapagliflozin on EChOcardiographic Measures of CarDiac StructurE and Function in Patients with Chronic Kidney Disease: the DECODE-CKD Trial de réir Bartholdy, KV, Johansen, ND, Landler, N, Skaarup, KG, Jensen, J, Bressendorff, I, Schou, M, Christensen, J, Feldt-Rasmussen, B, Vaduganathan, M, Solomon, S, Haynes, R, Persson, F, Rossing, P, Køber, L, Zannad, F, Hansen, D, Biering-Sørensen, T

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial de réir Judge, PK, Tuttle, KR, Staplin, N, Hauske, SJ, Zhu, D, Sardell, R, Cronin, L, Green, JB, Agrawal, N, Arimoto, R, Mayne, KJ, Sammons, E, Brueckmann, M, Shah, SV, Rossing, P, Nangaku, M, Landray, MJ, Wanner, C, Baigent, C, Haynes, R, Herrington, WG

A novel rare CUBN variant and three additional genes identified in Europeans with and without diabetes: results from an exome-wide association study of albuminuria de réir Ahluwalia, T, Schulz, C, Waage, J, Skaaby, T, Sandholm, N, Van Zuydam, N, Charmet, R, Bork-Jensen, J, Almgren, P, Thuesen, B, Bedin, M, Brandslund, I, Christensen, C, Linneberg, A, Ahlqvist, E, Groop, P, Hadjadj, S, Tregouet, D, Jørgensen, M, Grarup, N, Pedersen, O, Simons, M, Groop, L, Orho-Melander, M, McCarthy, M, Melander, O, Rossing, P, Kilpeläinen, T, Hansen, T

Making use of comparable health data to improve quality of care and outcomes in diabetes: the EUBIROD review of diabetes registries and data sources in Europe de réir Carinci, F, Štotl, I, Cunningham, SG, Poljicanin, T, Pristas, I, Traynor, V, Olympios, G, Scoutellas, V, Azzopardi, J, Doggen, K, Sandor, J, Adany, R, Løvaas, KF, Jarosz-Chobot, P, Polanska, J, Pruna, S, de Lusignan, S, Monesi, M, Di Bartolo, P, Scheidt-Nave, C, Heidemann, C, Zucker, I, Maurina, A, Lepiksone, J, Rossing, P, Arffman, M, Keskimäki, I, Gudbjornsdottir, S, Di Iorio, CT, Dupont, E, de Sabata, S, Klazinga, N, Benedetti, MM

The genetic landscape of renal complications in type 1 diabetes. de réir Sandholm, N, Van Zuydam, N, Ahlqvist, E, Juliusdottir, T, Deshmukh, H, Rayner, N, Di Camillo, B, Forsblom, C, Fadista, J, Ziemek, D, Salem, R, Hiraki, L, Pezzolesi, M, Trégouët, D, Dahlström, E, Valo, E, Oskolkov, N, Ladenvall, C, Marcovecchio, M, Cooper, J, Sambo, F, Malovini, A, Manfrini, M, McKnight, A, Lajer, M, Harjutsalo, V, Gordin, D, Parkkonen, M, Tuomilehto, J, Lyssenko, V, McKeigue, P, Rich, S, Brosnan, M, Fauman, E, Bellazzi, R, Rossing, P, Hadjadj, S, Krolewski, A, Paterson, A, Florez, J, Hirschhorn, J, Maxwell, A, Dunger, D, Cobelli, C, Colhoun, H, Groop, L, McCarthy, M, Groop, P

A genome-wide association study of diabetic kidney disease in subjects with type 2 diabetes de réir van Zuydam, NR, Ahlqvist, E, Sandholm, N, Deshmukh, H, Rayner, NW, Abdalla, M, Ladenvall, C, Ziemek, D, Fauman, E, Robertson, NR, McKeigue, PM, Valo, E, Forsblom, C, Harjutsalo, V, Perna, A, Rurali, E, Marcovecchio, ML, Igo, RP, Salem, RM, Perico, N, Lajer, M, Käräjämäki, A, Imamura, M, Kubo, M, Takahashi, A, Sim, X, Liu, J, van Dam, RM, Jiang, G, Tam, CHT, Luk, AOY, Lee, HM, Lim, CKP, Szeto, CC, So, WY, Chan, JCN, Ang, SF, Dorajoo, R, Wang, L, Clara, TS, McKnight, A-J, Duffy, S, Pezzolesi, MG, Consortium, G, Marre, M, Gyorgy, B, Hadjadj, S, Hiraki, LT, Ahluwalia, TS, Almgren, P, Schulz, C-A, Orho-Melander, M, Linneberg, A, Christensen, C, Witte, DR, Grarup, N, Brandslund, I, Melander, O, Paterson, AD, Tregouet, D, Maxwell, AP, Lim, SC, Ma, RCW, Tai, ES, Maeda, S, Lyssenko, V, Tuomi, T, Krolewski, AS, Rich, SS, Hirschhorn, JN, Florez, JC, Dunger, D, Pedersen, O, Hansen, T, Rossing, P, Remuzzi, G, Brosnan, MJ, Palmer, CNA, Groop, P-H, Colhoun, HM, Groop, LC, McCarthy, MI